ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Other Receivables
ADC Therapeutics SA
Other Receivables Peer Comparison
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Receivables
CHf622k
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Receivables
CHf30.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
24%
|
|
Idorsia Ltd
SIX:IDIA
|
Other Receivables
CHf45m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Receivables
CHf801k
|
CAGR 3-Years
37%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Other Receivables?
Other Receivables
0
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Other Receivables amounts to 0 USD.